Aeglea BioTherapeutics, Inc. (AGLE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.68B |
| Enterprise Value | 6.59B |
| P/E Ratio | -45.11 |
| PEG Ratio | 0.89 |
| Price/Sales Ratio | 94.36 |
| Price/Book Ratio | 50.72 |
| Enterprise/Revenue | 93.29 |
| Enterprise/EBITDA | -41.94 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -1.98 |
| Operating Margin | -2.23 |
AD
Management Effectiveness
| Return On Assets | -0.23 |
| Return On Equity | -0.31 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0.26 |
| Gross Profit | 0 |
| EBITDA | -155.22M |
| Net Income | -155.2M |
| Diluted EPS | -1.98 |
Balance Sheet
| Total Cash | 741.47M |
| Total Cash/Share | 2.14 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 8.97 |
| Book Value Per Share | 1.94 |
Price History
| 52-Week Change | 23.81 |
| 52-Week High | 24 |
| 52-Week Low | 2.66 |
| Moving Average 50 Days | 12.64 |
| Moving Average 200 Days | 9.84 |
Statistics
| Average Volume | 59,537 |
| Shares Outstanding | 4.05M |
| % Held by Institutions | 0.2 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | September 08, 2023 |
AD
